We're honored to have the announcement of the new CEO of Plan A?, Darlene Walley, PhD, celebrated and featured in Fortune's MPW Daily with Emma Hinchliffe! MPW Daily is the premier newsletter featuring the world’s most powerful women in business and leadership. Our team is beyond excited to have Dr. Walley leading our team as a true mover and shaker in the healthcare space. Join us again in celebrating Dr. Walley! https://buff.ly/4edbXM4 #planaformen #plana #malebirthcontrol #birthcontrol #malecontraceptive #malecontraception #healthcarenews #reproductivehealth #fortune #mpwdaily #mostpowerfulwomen #moversandshakers
NEXT Life Sciences, Inc.
生物技术研究
NEXT Life Sciences Introduces Plan A? A revolutionary, non-hormonal, reversible procedure that will bring the scientific
关于我们
NEXT Life Sciences is a medical device company that plans to deliver the first male contraceptive solution that is non-hormonal, long lasting, and reversible.
- 网站
-
https://nextlifesciences.org/
NEXT Life Sciences, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 类型
- 私人持股
- 创立
- 2020
NEXT Life Sciences, Inc.员工
动态
-
We’re pleased to announce today that Darlene Walley, PhD, an expert with over 30 years of executive experience in life sciences, has been named the CEO of Plan A? and that Peter Hutt, former Chief Counsel to the FDA, has joined the Advisory Board for NEXT Life Sciences, Inc. “We are thrilled to bring Dr. Walley on as the CEO of Plan A? with her extensive background, expertise in biotech and pharma, and passion for bringing transformative products to market.” said L.R. Fox, who will remain CEO of parent company NEXT Life Sciences, “I am also pleased to welcome Peter to our advisory Board, his exceptionally accomplished legal and policy career will help us advance our mission of bringing a new generation of accessible contraception to the market.” In addition to leading the continued development efforts for Plan A?, both Dr. Walley and Peter Barton Hutt will work alongside L.R. Fox to develop new and modern reproductive healthcare solutions at NEXT Life Sciences! Please join us in welcoming these members to our team! https://buff.ly/40i3p39
-
We're so grateful to have brilliant experts like Dr. John Amory as a part of our Medical Advisory Board here at NEXT Life Sciences, Inc.! In a new piece written for The Seattle Times, Dr. Amory sums up perfectly the current urgency for new male contraceptives like Plan A?: "Many men are already very active in trying to prevent pregnancy — and the landscape for reproductive health in the U.S. has made men’s quest for birth control even more urgent. Men want effective, long-lasting birth control solutions.... Now is the time to empower men, as well as women, with the tools they need to make informed choices about their reproductive health and future." You can read his article in full at the link here: https://buff.ly/4ghqNDw
-
Scott Nelson from MD+DI tapped into advice from our CEO L.R. Fox to highlight what it takes to develop a successful product in MedTech. "As an entrepreneur who likes to try his hand at different industries, Fox understands the value of experience and actively seeks out domain experts and leaders in the pertinent field. He asks himself, “If there's one person that I need to talk to to really understand this, who is that person?” This attitude opens doors to valuable partnerships, collaborations, and opportunities for further innovation." Read Scott's article in full at: https://buff.ly/3MqNpmY
-
#HealthTransformer L.R. Fox of StartUp Health company NEXT Life Sciences, Inc., weighs in on how to tailor a product effectively to integrate into the often-resistant healthcare system. Read: https://ow.ly/P6kX50T6xFC
-
In my latest op-ed for MD+DI, I explore key strategies for driving the adoption of novel #medicaldevices based on insights from seasoned leaders featured on Medsider. Here’s a preview: ?? Greg Bullington, CEO of Magnolia Medical Technologies, emphasizes using robust data to build credibility and support from government bodies and influential stakeholders. ?? L.R. Fox of NEXT Life Sciences, Inc., talks about using insights gathered from stakeholders, users, and regulators to adapt your device and communicate its value. ?? John Bertrand, CEO of Digital Diagnostics shares how he created buy-in for their technology through immersive collaboration with clinicians to create ‘aha’ moments. ?? Patrick Anquetil, CEO of Portal Instruments, suggests aligning your solution with the economic interests of key ecosystem players such as strategic partnerships with multi-national corporations. ?? Gabriel Jones, CEO of Proprio, outlines the importance of creating platform technologies that complement and enhance other products. For more insights from these proven leaders, read the full article here: https://lnkd.in/g8n4zc_2 As always, thanks to Omar Ford, Amanda Pedersen, and Katie Hobbins for their publishing support! ????
A Guide to Widespread Therapy Adoption in the Medical Device Industry
mddionline.com
-
“Being informed about birth control options and helping bear the burden of pregnancy prevention are great ways to demonstrate your care for your partner and their wellbeing.” A quote from sexuality educator and writer Erika Fore in her piece The Gentleman's Guide to Birth Control, which covers how knowing more about birth control makes you a better partner and features an interview with our CEO L.R. Fox about the future of male contraception! https://buff.ly/3WyOI82
-
Our CEO L.R. Fox envisions Plan A? becoming the primary choice for family planning worldwide. "We’re talking to stakeholders including regulators in the US, UK, and Europe about Plan A clinical trials in order to ultimately help many nations who eagerly seek male contraception.” Read the article in full on The Breakthrough here! https://buff.ly/3Sgi9ue #UnintendedPregnancy #ReproductiveHealth #PlanA #MaleContraceptive #BirthControl #Vasectomy
TRIALS of a revolutionary ‘switch-on/off’ contraceptive could begin in the UK, Australia, and New Zealand as early as next year
https://thebreakthrough.news
-
#HealthTransformer L.R. Fox, CEO of StartUp Health company NEXT Life Sciences, Inc., said they're seeing growing interest in their non-hormonal birth control options for men. “We see an outpouring of support from men,” said Fox. “They see that their partner is either using contraception that's not working for them, or they aren't able to use contraception and they're trying to find solutions.” #HealthMoonshot https://ow.ly/oO9b50SCLXX
New male birth control options are in the works
spectrumlocalnews.com
-
Our journey with Plan A is making headlines! Watch Erin Billups interview our CEO L.R. Fox for NY1 News and discuss why the timeline to get #malebirthcontrol options to market is so important. #UnintendedPregnancy #ReproductiveHealth #PlanA #MaleContraceptive #BirthControl #SupremeCourt #RoevWade #Vasectomy This interview has been edited for length and clarity. The full interview can be found on NY1 Spectrum News at https://lnkd.in/gM8b6JKn